Skip to content
10-Q

Quarterly Report

HypGen Inc

0001662252-17-000212

← back to feed
Filed
Oct 16, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Oct 14, 2017 135.8M sh
Operating Cash Flow Q1 2017 · Aug 31, 2017 −$260.11K
Operating Cash Flow Q1 2017 · Aug 31, 2016 −$123
Stockholders Equity Q1 2017 · Aug 31, 2017 −$202.96K
Stockholders Equity Q1 2017 · May 31, 2017 −$192.91K
Total Liabilities Q1 2017 · Aug 31, 2017 $438.44K
Total Liabilities Q1 2017 · May 31, 2017 $215.08K
Current Assets Q1 2017 · Aug 31, 2017 $235.49K
Current Assets Q1 2017 · May 31, 2017 $22.17K
Total Assets Q1 2017 · Aug 31, 2017 $235.49K
Total Assets Q1 2017 · May 31, 2017 $22.17K
Sga Expense Q1 2017 · Aug 31, 2017 $92.99K
Sga Expense restated Q1 2017 · Aug 31, 2016 $17.5K
Rd Expense Q1 2017 · Aug 31, 2017 $0
Rd Expense Q1 2017 · Aug 31, 2016 $0
Net Income Q1 2017 · Aug 31, 2017 −$353.62K
Net Income Q1 2017 · Aug 31, 2016 −$351
Operating Income Q1 2017 · Aug 31, 2017 −$341.79K
Operating Income Q1 2017 · Aug 31, 2016 $17.5K